Pyxis.AI was hit with a breach-of-contract lawsuit on Jan. 29 in California Superior Court for San Bernardino County over an allegedly unpaid $250,000 convertible promissory note. The action, brought ...
Pyxis Oncology Inc. (NASDAQ: PYXS) on Thursday released preliminary data from its ongoing Phase 1 studies of micvotabart pelidotin (MICVO) for recurrent/metastatic head and neck squamous cell ...
Shares of Pyxis Oncology dropped after the pharmaceutical company said data from its trials on a treatment for a form of head and neck cancer showed a high incidence of adverse effects. The stock fell ...
Pyxis Oncology ( (PYXS)) has provided an announcement. On December 18, 2025, Pyxis Oncology reported positive preliminary Phase 1 data for its first-in-concept antibody-drug conjugate MICVO in ...
For James Westlake, a recent Naked Wines campaign required a camera able to produce excellent images in a fast, lightweight, handheld setup, and the PYXIS 12K fit the bill. James Westlake is a UK ...
LONDON, Nov. 18, 2025 /PRNewswire/ -- Compass Box Scotch Whiskymakers announce the launch of Pyxis, a first-of-its-kind AI-powered whisky guide designed to make exploration more personal, effortless, ...
Most camper van conversions we cover here on autoevolution are based on brand-new vans. However, a slightly older chassis works just as well and can help save you a decent amount of money. Today, I'm ...
Fintel reports that on November 4, 2025, Guggenheim maintained coverage of Pyxis Oncology (NasdaqGS:PYXS) with a Buy recommendation. Analyst Price Forecast Suggests 60.63% Upside As of October 30, ...
As of October 30, 2025, the average one-year price target for Pyxis Oncology is $6.12/share. The forecasts range from a low of $5.05 to a high of $8.40. The average price target represents an increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results